Alpha-naphthylisothiocyanate (ANIT) causes cholestatic hepatitis characterized by intrahepatic bile duct epithelial cell injury and periportal hepatocellular necrosis. The progression of ANITinduced hepatocyte injury is reported to involve extrahepatic cells including platelets. We showed recently that the procoagulant protein tissue factor (TF) is essential for ANIT-induced coagulation and contributes to ANIT-induced liver necrosis. Platelets have been shown to express TF and can contribute to coagulation cascade activation. To this end, we tested the hypothesis that platelet-dependent coagulation contributes to ANIT-induced liver injury. In ANIT (60 mg/kg)-treated mice, activation of the coagulation cascade occurred prior to a decrease of platelets in the blood. Immunostaining for glycoprotein IIb (CD41) revealed platelet accumulation along the borders of necrotic foci in livers of ANIT-treated mice. Antibody-mediated platelet depletion did not affect coagulation but markedly affected liver histopathology in ANIT-treated mice. Platelet depletion induced marked pooling of blood within necrotic lesions consistent with parenchymal-type peliosis as early as 24 h after ANIT treatment. In contrast, treatment with the P2Y 12 inhibitor clopidogrel significantly reduced ANIT-induced hepatocyte necrosis and serum alanine aminotransferase activity but did not exaggerate bleeding into necrotic foci. Clopidogrel also reduced hepatic neutrophil accumulation but did not affect induction of Intercellular adhesion molecule-1 or chemokine CxC motif ligand-1 messenger RNA expression in liver. The data indicate that ANIT-induced coagulation is platelet independent and that platelets contribute to ANIT-induced hepatocyte necrosis by promoting neutrophil accumulation. In contrast, severe thrombocytopenia induces parenchymal-type peliosis in the livers of ANIT-treated mice, a rare hepatic lesion associated with pooling of blood in the liver.
Acute intrahepatic cholestatic liver injury is modeled by administration of the xenobiotic alpha-naphthylisothiocyanate (ANIT), which selectively injures intrahepatic bile duct epithelial cells (BDECs) after administration by oral gavage (Plaa and Priestly, 1976) . Damage to bile ducts causes the release of high concentrations of bile acids into the liver sinusoids. Although bile acids are cytotoxic to hepatocytes (Perez and Briz, 2009) , several studies suggest that the progression of acute cholestatic liver injury involves multiple mediators. For example, neutrophil depletion or deficiency in the b2 integrin CD18 reduced liver necrosis induced by bile duct ligation (BDL) or ANIT treatment (Dahm et al., 1991; Gujral et al., 2003; Kodali et al., 2006) . The coagulation cascade also contributes to BDL-induced and ANIT-induced liver injury (Abdel-Salam et al., 2005; Luyendyk et al., 2009) . Platelets also appear to contribute to cholestatic liver injury (Bailie et al., 1994; Laschke et al., 2008) . Taken together, these studies indicate an important role of elements of blood in cholestatic liver injury.
Previous studies using BDL as a model of obstructive cholestasis indicated that platelets contribute to cholestatic liver injury by promoting induction of chemotactic factors and the accumulation of neutrophils in the liver (Laschke et al., 2008) . However, it is not clear whether this mechanism is shared in other models of cholestatic injury. It is possible that platelets contribute to cholestatic liver injury via other mechanisms. For example, we have shown that ANIT-induced liver injury is reduced in mice deficient in the procoagulant protein tissue factor (TF), suggesting that the coagulation cascade contributes to the pathogenesis (Luyendyk et al., 2009) . Activated platelets possess a thrombogenic surface capable of propagating coagulation cascade activation (Ofosu, 2002) . Platelets have been shown to express TF via a functional spliceosome (Schwertz et al., 2006) . Accordingly, platelet activation and accumulation in the livers of ANIT-treated mice could contribute to liver injury by activating the coagulation cascade. However, the role of platelets in the procoagulant response induced by cholestatic liver injury has not been evaluated.
Interestingly, in addition to the potential for damaging effects of platelets during acute liver injury, they may also serve a protective function. Some studies implicate the release of serotonin by platelets as a mediator of liver regeneration and repair after partial hepatectomy (Lesurtel et al., 2006) , although this is not necessarily true for other types of liver injury (Lang et al., 2008; Nocito et al., 2007) . Other studies have suggested that mediators released by platelets, such as sphingosine-1-phosphate and serotonin, can affect sinusoidal endothelial cell (SEC) fenestration and inhibit SEC injury (Braet et al., 1995; Zheng et al., 2006) . It is also possible that platelets limit hemorrhage secondary to SEC damage during early cholestasis, although this possibility has not been investigated.
We sought to clarify the role of platelets in the procoagulant response and hepatocyte damage elicited by acute xenobioticinduced cholestatic liver injury utilizing both platelet depletion (i.e., anti-CD41 antibody) and inhibition (i.e., clopidogrel) strategies. Biomarkers of coagulation, liver injury, and inflammatory cell accumulation were assessed. The results indicate divergent effects of platelet depletion and platelet inhibition on the progression of acute cholestatic liver injury.
MATERIALS AND METHODS
Mice and treatment models. Male, wild-type C57Bl/6J mice used for these studies were purchased from the Jackson Laboratory. Mice were maintained in an Association for Accreditation and Assessment of Laboratory Animal Care International (AAALAC)-accredited facility at the University of Kansas Medical Center. Mice were housed at an ambient temperature of 22°C with alternating 12-h light/dark cycles and allowed water and rodent chow ad libitum (Teklad, 8604; Harlan, Indianapolis, IN). All animal procedures were performed according to the guidelines of the American Association for Laboratory Animal Science and were approved by the University of Kansas Medical Center Institutional Animal Care and Use Committee.
After removal of food overnight, mice were given ANIT (Sigma-Aldrich, St. Louis, MO) (60 mg/kg, po) in a volume of corn oil determined by the weight of the mouse (i.e., 10 ml/kg body weight) or an equivalent volume of corn oil (vehicle control). Various times after ANIT treatment, the mice were anesthetized with isoflurane and blood collected from the caudal vena cava into citrate (for thrombin-antithrombin [TAT] determination), EDTA (for platelet quantification), or an empty syringe for the collection of serum. Plasma and serum were collected by centrifugation. Sections of liver from the left lateral lobe were fixed in neutral-buffered formalin for 48 h. The right medial lobe was affixed to a cork with optimal cutting temperature compound and frozen for 3 min in liquid nitrogen-chilled isopentane. The remaining liver was snap frozen in liquid nitrogen. For platelet depletion studies, mice were given a single dose of endotoxin-and azide-free anti-CD41 antibody (clone, MWReg30) (1 mg/kg in sterile PBS) custom prepared by BioLegend (La Jolla, CA) or 1 mg/kg isotype control rat immunoglobulin G (IgG) (BioXCell, West Lebanon, NH) 16 h before ANIT administration. For platelet inhibition studies, clopidogrel (Axxora, San Diego, CA) dissolved in sterile PBS or sterile PBS was given 8 h (30 mg/kg, ip) after ANIT treatment, followed by additional injections every 12 h (30 mg/kg, ip) until completion of the experiment.
Histopathological analysis and immunofluorescent staining. Formalinfixed livers were processed routinely, embedded in paraffin, sectioned at 5 lm, and stained with hematoxylin and eosin. Slides were evaluated by light microscopy by a Board-certified pathologist (O.T.). Liver specimens were carefully evaluated for evidence of inflammation, steatosis, fibrosis, necrosis, and peliosis. Necrosis was scored as 0-4 based on extent of necrosis as described previously (Luyendyk et al., 2009) . Areas without necrosis were scored as 0, and areas with extensive necrosis are scored as 4. Multiple cystlike, blood-filled cavities of variable sizes, shapes, and numbers within liver parenchyma characteristically known as ''peliosis'' were noted in several mice with different treatments as discussed below. In none of the cases was ''phlebectatic peliosis'' characterized by histological features of regular bloodfilled cavities lined by endothelial cells identified. Instead, the only type of peliosis that was noted was of the ''parenchymal type,'' where various blood-or fibrin-filled irregular cystic parenchymal spaces were identified, surrounded, and intermixed with necrotic, degenerated hepatocytes. The extent of this parenchymal peliosis was graded into rare (rare minute microscopic foci of peliosis), moderate (moderate sized, multiple areas of peliosis), or severe (multiple, large-sized coalescent foci). For platelet and fibrin staining, frozen sections cut at 8 lm were fixed in 4% neutral-buffered formalin for 10 min at room temperature, washed 3 times with PBS, and blocked with 10% goat serum in PBS (block buffer) for 1 h. Sections were incubated with the primary antibodies rabbit anti-human fibrinogen (1:5000; Dako, Carpinteria, CA) and/or rat anti-mouse CD41 (1:1000; Serotec, Raleigh, NC) diluted in block buffer for 2 h at room temperature. The slides were washed and incubated with Alexa 488-and Alexa 594-conjugated secondary antibodies (Invitrogen, Carlsbad, CA) diluted in block buffer þ 2% mouse serum for 2 h. The slides were then washed with PBS, and fluorescent staining of the liver sections was visualized using an Olympus BX41 microscope (Olympus, Lake Success, NY). Images were captured using an Olympus DP70 and merged using the Olympus DP Manager software. Quantification of CD41 area was performed utilizing Scion Image as described previously (Yee et al., 2003) .
Clinical chemistry, platelet quantification in blood, and TAT measurement. The serum activities of alanine aminotransferase (ALT) and alkaline phosphatase (ALP) were determined using commercially available reagents (Pointe Scientific, Canton, MI). TAT levels in plasma were determined using a commercially available ELISA Kit (Siemens Healthcare Diagnostics, Deerfield, IL). Quantification of platelets was performed on EDTA-anticoagulated whole blood utilizing a Beckman Coulter LH 780.
RNA isolation, complementary DNA synthesis, and real-time PCR. RNA was isolated from 75 mg of snap-frozen liver using TRI Reagent (Molecular Research Center, Inc., Cincinnati, OH) according to the manufacturer's protocol. One microgram of RNA was utilized for the synthesis of complementary DNA (cDNA) using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) and MyCycler Thermal Cycler (Bio-Rad, Hercules, CA). Levels of Cxcl1 (KC), Intercellular adhesion molecule-1 (ICAM-1), and 18S messenger RNA (mRNA) were determined using TaqMan gene expression assays and TaqMan gene expression master mix (Applied Biosystems) on a StepOnePlus sequence detection system (Applied Biosystems). The expression of KC and ICAM-1 mRNA was normalized relative to 18S expression levels and relative expression level determined using the comparative Ct method.
Tissue myeloperoxidase activity. Neutrophil accumulation in liver was estimated by measuring liver homogenate myeloperoxidase (MPO) activity. One hundred milligrams of frozen liver was homogenized in a buffer containing 0.5% hexadecyl trimethyl ammonium bromide, 10mM EDTA, and 50mM Na 2 PO 4 , pH 5.4, and subjected to three freeze-thaw cycles followed by centrifugation at 12,000 3 g for 15 min at 4°C. MPO activity in the supernatant was determined by addition of 50mM Na 2 PO 4 containing 0.167 mg/ml o-dianisidine dihydrochloride (Sigma-Aldrich) and 0.0005% hydrogen peroxide (Sigma-Aldrich) in 50mM phosphate buffer (pH 6.0). MPO activity was expressed as the change in absorbance measured at 460 nm/mg of protein in the liver homogenate. The concentration of protein in liver homogenate was determined using a bicinchoninic acid assay (Pierce).
Statistics. Comparison of two groups was performed using Student's t-test.
Comparison of three or more groups was performed using one-way ANOVA and Student-Newman-Keul's post hoc test. Where data were not normally distributed, comparisons were made by ANOVA on ranks and Student-Newman-Keul's post hoc test. The criterion for statistical significance was p < 0.05.
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RESULTS
Time Course of ANIT-Induced Hepatic Platelet
Accumulation, Coagulation, and Liver Injury First, we determined the relative time course of thrombocytopenia, coagulation cascade activation, and liver injury in mice treated with ANIT. Serum ALT and ALP activities were slightly elevated in ANIT-treated mice at 24 h, and injury progressed further by 48 h (Figs. 1A and 1B) . In agreement with our previous studies (Luyendyk et al., 2009) , plasma TAT concentration increased dramatically at 24 h and increased further by 48 h (Fig. 1C ). An increase in TAT in the plasma indicates generation of the coagulation protease thrombin. Interestingly, the increase in plasma TAT concentration preceded a decrease in platelets in the blood. A decrease in platelets in blood was observed at 48 h after ANIT treatment (Fig. 1D) . Of importance, the results indicate that coagulation precedes the decrease in platelets in blood of ANIT-treated mice. Scattered CD41-positive (i.e., platelet) staining consistent with localization to the sinusoids and larger vessels was observed in liver sections from vehicle-treated mice ( Fig. 2A) and within larger vessels. In agreement with previous studies (Luyendyk et al., 2009; Yee et al., 2003) , fibrin staining in livers from vehicle-treated mice was restricted to the intima of larger vessels (Figs. 2B and 2C ). The marked decrease in blood platelets in ANIT-treated mice at 48 h was associated with increased platelet accumulation within areas of hepatic necrosis (i.e., bile infarcts) (Fig. 2D) . Fibrin deposition also occurred within areas of necrosis in ANIT-treated mice (Figs. 2E and 2F).
Effect of Platelet Depletion on ANIT-Induced Coagulation
and Liver Injury Platelet depletion was accomplished using an anti-CD41 antibody, clone MWReg30. Previous studies have utilized this antibody to specifically deplete platelets in mice (Lesurtel et al., 2006) . Platelet depletion with the anti-CD41 antibody alone did not cause liver injury (data not shown). Pretreatment with the anti-CD41 antibody dramatically reduced blood platelets in ANIT-treated mice at 24 and 48 h (Fig. 3A) . Interestingly, platelet depletion did not affect ANIT-induced coagulation, as indicated by increased plasma TAT concentration at 24 and 48 h (normal levels < 5 ng/ml) (Fig. 3B) . This is in agreement with our finding that coagulation preceded a decrease in platelets in the blood in ANIT-treated mice. Platelet depletion did not affect serum ALP activity in ANITtreated mice at either 24 or 48 h (Fig. 3C) . Interestingly, serum ALT activity was substantially increased by platelet depletion in ANIT-treated mice at 24 h (Fig. 3D ). While serum ALT activity did not increase further in platelet-depleted mice given ANIT, serum ALT activity increased further by 48 h in ANITtreated mice given control antibody (Fig. 3D) .
Effect of Platelet Depletion on Liver Histopathology in ANITTreated Mice
Liver necrosis induced by ANIT is characterized by areas of periportal necrosis containing bile and is associated with marked inflammatory cell accumulation (Becker and Plaa, 1965; Plaa and Priestly, 1976) . We have described the liver histopathology associated with high-dose ANIT administration previously (Luyendyk et al., 2009) . Of importance, these so-called ''bile infarcts'' were evident in the livers of ANIT-treated mice given control IgG at 24 h (Fig. 4A) , and the size and frequency of necrotic lesions increased in these mice by 48 h (Fig. 4D) ( Table 1) . Red blood cell infiltration of necrotic areas was evident in mice given ANIT and control IgG, and this was somewhat increased at 48 h (Table 1) . Interestingly, platelet depletion increased the severity of necrotic lesions in ANITtreated mice at 24 h, and this was associated with substantial pooling of blood within areas of necrosis, a lesion consistent with parenchymal-type peliosis (Tsokos and Erbersdobler, 2005) . Peliosis was evident both in proximity to periportal necrosis (Fig. 4B) , and in regions of the liver, several hepatocytes away from damaged bile ducts (Fig. 4C) . Peliosis was also prominent in these mice at 48 h (Fig. 4F) , and in contrast to mice given control IgG, the severity of necrosis did not substantially increase between 24 and 48 h ( Table 1) .
Inhibition of Platelet Activation Reduces ANIT-Induced Liver
Injury: Evidence for Platelet-Dependent Neutrophil Accumulation
As opposed to depleting all platelets, we next utilized the P2Y 12 receptor antagonist clopidogrel to inhibit platelet activation. Administration of clopidogrel alone did not affect (Figs. 6A and 6B ). In contrast, clopidogrel substantially reduced hepatic neutrophil accumulation, as indicated by reduced liver homogenate MPO activity (Fig. 6C ).
DISCUSSION
Platelets have been implicated in the pathogenesis of multiple types of liver damage including viral hepatitis (Lang et al., 2008) , ischemia-reperfusion (Yadav et al., 1999) , BDL (Laschke et al., 2008) , and injury induced by xenobiotics including concanavalin A (Massaguer et al., 2002; Miyazawa et al., 1998) , and lipopolysaccharide (Pearson et al., 1995) . Our data agree with a previous study showing that platelet depletion in rats (Bailie et al., 1994) reduces ANIT-induced liver necrosis. Platelet inhibition reduced the severity of liver necrosis in ANITtreated mice. However, platelet depletion exacerbated a perhaps underappreciated lesion in ANIT-treated mice characterized by pooling of blood in areas of necrosis (i.e., peliosis). The data support the hypothesis that platelets have both protective and damaging effects in ANIT-induced liver injury.
Our previous work indicated that ANIT-induced coagulation cascade activation is TF dependent and that TF contributes to the progression of ANIT-induced liver injury. Insofar as platelets can express TF and contribute to activation of the coagulation cascade (Ofosu, 2002; Schwertz et al., 2006) , we examined their involvement in this capacity in ANIT-induced liver injury. The results presented herein indicate that blood platelets are reduced after coagulation cascade activation, and 
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platelet depletion did not affect thrombin generation. This indicates that coagulation cascade activation is not dependent on platelets in ANIT-treated mice and that another cell type expressing TF is important for coagulation in this model. Indeed, we have shown that BDECs express TF (Luyendyk et al., 2009) , and the initial destruction of these cells by ANIT may cause TF-dependent coagulation. Moreover, TF expressed by other cells in the liver such as hepatocytes (Stephenne et al., 2007) could contribute to ANIT-induced coagulation.
Platelets appear to modify hepatocellular injury in ANITtreated mice by impacting hepatic accumulation of inflammatory cells. Clopidogrel treatment reduced neutrophil accumulation in the livers of ANIT-treated mice. Of importance, platelet depletion did not significantly reduce liver homogenate MPO activity 48 h after ANIT treatment (71 ± 15 vs. 130 ± 62), although direct comparison of these results is complex as leukocyte infiltration may be driven by additional mechanisms under conditions of peliosis induced by complete platelet deficiency. It has also been shown after BDL that platelet depletion reduced neutrophil accumulation in liver, as well as hepatic ICAM-1 and chemokine CxC motif ligand-1 mRNA levels (Laschke et al., 2008) . In contrast, clopidogrel treatment did not affect hepatic expression of ICAM-1 or KC mRNAs in ANIT-treated mice. Adhesion molecules on the surface of activated platelets, including GPIIb/IIIa and P-selectin, interact directly with integrins and selectins on the surface of neutrophils (Zarbock et al., 2007) . Of interest, a P-selectin antibody decreased the accumulation of neutrophils in liver after BDL (Laschke et al., 2008) . Interactions between platelets, neutrophils, and SECs may be critical for promoting neutrophil accumulation in the livers of ANIT-treated mice.
The mechanisms by which platelets are recruited and activated in the livers of ANIT-treated mice have not been determined. While we sought to evaluate the role of platelets in activating the coagulation cascade, the time course of coagulation and of platelet activation suggests the possibility of the opposite relationship. That is, that the coagulation cascade is a mediator of platelet activation during cholestatic liver injury. Thrombin is a potent activator of platelets via proteaseactivated receptors (PARs). Thrombin activation of human platelets requires PAR-1 (Trejo et al., 1996) , whereas in mice, PAR-3 and PAR-4 are required (Kahn et al., 1998) . In addition to eliciting intracellular signaling in platelets, the interaction of these cells with cross-linked fibrin (Lupu et al., 2005) within areas of necrosis in ANIT-treated mice could be an important mechanism for platelet accumulation. Indeed, platelets colocalized with fibrin in areas of necrosis in livers of ANIT-treated mice. Additional studies clarifying the role of thrombin and fibrin in the platelet activation observed in ANIT-treated mice are required. Necrosis (score) 1.4 (0,1,2,2,2) 3 (3,3,3) 4 (4,4,4,4,4) 3.6 (3,3,4,4,4) 
Note. Mice were given 1 mg/kg of anti-CD41 antibody (MWReg30) or isotype control antibody 16 h prior to treatment with ANIT (60 mg/kg, po), and livers were collected 24 or 48 h later. The severity of necrosis in liver sections was assigned a score from 0 to 4, increasing in severity as described in Materials and Methods section. Average necrosis scores and the score for each animal are shown. Parenchymal-type peliosis in liver sections was categorized as absent (A), rare microscopic foci (R), multiple lesions moderate in size (M), or multiple large-sized coalescent foci (P).
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Previous studies have implicated platelets as mediators of liver damage during cholestasis (Bailie et al., 1994; Laschke et al., 2008) . Depletion of platelets in rats limited the progression of ANIT-induced hepatocellular injury but did not affect biomarkers of biliary injury (Bailie et al., 1994) . The present results agree with those described previously, insofar as a pharmacological inhibitor of platelet activation (i.e., clopidogrel) reduced hepatocyte necrosis in ANIT-treated mice but did not impact serum ALP activity, an indicator of cholangiocyte damage. However, in striking contrast to platelet depletion in rats, platelet depletion in ANIT-treated mice exacerbated the pooling of blood within necrotic lesions, consistent with parenchymal-type peliosis (Tsokos and Erbersdobler, 2005) . This variant of peliosis is typified by pooling of blood within or adjacent to necrotic tissue, and the lesions are not necessarily bordered by endothelium or fibrotic material, the latter being a hallmark of another peliosis variant called phlebectatic peliosis (Tsokos and Erbersdobler, 2005) . The basis for this lesion in our study but not in plateletdepleted ANIT-exposed rats is not clear but could relate to multiple factors including differences in species, fasting, severity of liver injury, or use of whole antiserum versus anti-CD41 antibody. Of importance, the anti-CD41 (GP11bIIIa) antibody commonly utilized to examine the role of platelets in tissue injury has systemic effects, including transient induction of hypothermia and lung injury (Nieswandt et al., 1999 (Nieswandt et al., , 2000 . Moreover, complexes of this antibody and platelets accumulate in the liver after administration and may be cleared by Kupffer cells (Bagchus et al., 1989) . This could impact normal hepatic homeostasis.
Peliosis hepatis in patients is a relatively rare clinical finding associated with a variety of diseases and treatment with various drugs including 6-mercaptopurines and steroids (Tsokos and Erbersdobler, 2005) . Peliosis in the liver has also been described in rodent models of exposure to xenobiotics including 2,3,7,8-tetrachlorodibenzo-p-dioxin (Niittynen et al., 2003) , cadmium (Habeebu et al., 1998; Tzirogiannis et al., 2006) , hexachlorobenzene (Carthew and Smith, 1994) , and anabolic steroids (Stang-Voss and Appell, 1981; Tsirigotis et al., 2007) . Interestingly, peliosis has been reported in the context of cholestatic liver injury in rodent models (Niittynen et al., 2003; Romagnuolo et al., 1998) and in patients (Hayward et al., 1991; Russmann et al., 2001) . Moreover, in some patients, peliosis in liver and pancreas has been associated with exaggerated coagulation and thrombotic thrombocytopenic purpura (Belovejdov et al., 2008; Samyn et al., 2004) , a somewhat counterintuitive finding in the context of altered hemostasis in liver. Of importance, peliosis in ANITtreated mice depleted of platelets occurred in the presence of Note. Mice were treated with ANIT (60 mg/kg, po) and then subsequently with clopidogrel (30 mg/kg, ip) or sterile PBS 8, 20, and 32 h later. Livers were collected 48 h after ANIT treatment, and the severity of necrosis in liver sections was assigned a score from 0 to 4, increasing in severity as described in Materials and Methods section. Average necrosis scores and the score for each animal are shown. marked coagulation, as indicated by increased plasma TAT concentration. However, a definitive mechanistic role of either the coagulation cascade or platelets in the pathogenesis of peliosis has not been described.
It is curious in our study that a near complete depletion of platelets caused peliosis in ANIT-treated mice at 24 h, a time point at which ANIT alone had minimal effect on the number of platelets in the blood. It is possible that the accumulation of very few platelets is required to limit peliosis in the liver during cholestasis. Indeed, although we did not detect a difference in platelet numbers in blood, the number of platelets in the sinusoids increased 24 h after ANIT treatment (Supplementary fig. 1 ). Indeed, the upregulation of adhesion molecules, such as P-selectin, on the surface of platelets may precede an observable decrease in blood platelets. Additional studies are required to determine the time course of P-selectin upregulation on platelets in this model. The pathogenesis of peliosis has been proposed to stem from perturbed sinusoidal endothelial cell function in the liver (DeLeve, 2007; Tsokos and Erbersdobler, 2005) , including induction of cell death, and it is possible that initial platelet accumulation in the liver during cholestasis limits SEC dysfunction that leads to peliosis. Indeed, cholestatic liver injury is associated with SEC dysfunction, and bile acids can activate intracellular signaling pathways in SECs (Keitel et al., 2007; Yoshidome et al., 2000) . Platelet release of sphingosine-1-phosphate has been shown to be cytoprotective to endothelial cells (Zheng et al., 2006) . Moreover, serotonin released from platelets promotes liver regeneration and has been shown to alter SEC fenestration (Braet et al., 1995) . Another possibility is that the accumulation of platelets at the expanding edge of necrotic lesions constitutes a cellular barrier to limit bleeding into necrotic areas. To this end, severe thrombocytopenia and concurrent cholestasis may be risk factors for developing peliosis. Additional studies are warranted to determine the mechanism whereby platelets can prevent peliosis during cholestasis.
In summary, the results indicate that in ANIT-induced cholestatic liver injury, hepatic platelet accumulation promotes neutrophil accumulation and hepatocyte necrosis, but not coagulation cascade activation. Of importance, the finding of peliosis in livers of ANIT-treated mice after platelet depletion suggests that severe thrombocytopenia may render the liver susceptible to peliosis during cholestasis.
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